Publication | Closed Access
Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion
47
Citations
32
References
2013
Year
The survival benefit of HIPEC as an adjuvant therapy for gastric cancer patients with serosal invasion should be validated in a large cohort.
| Year | Citations | |
|---|---|---|
Page 1
Page 1